Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's Location: Aurora, Illinois 24 trials found
New Search
Filter
Trial Phase
Study Type
Late Onset Alzheimer's Disease
N/AOBSERVATIONAL Washington D.C., District of Columbia +4 more
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2, PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
PHASE3INTERVENTIONAL Long Beach, California +4 more
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
PHASE4INTERVENTIONAL Irvine, California +4 more
RECRUITING
Trial-Ready Cohort-Down Syndrome (TRC-DS)
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
N/AOBSERVATIONAL Atlantis, Florida +4 more
RECRUITING
Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
NAINTERVENTIONAL Chicago, Illinois
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
PHASE3INTERVENTIONAL Fullerton, California +4 more
RECRUITING
Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
N/AOBSERVATIONAL Chicago, Illinois
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
CommunityRx-Dementia + Peer Navigation (CRxDpeer)
NAINTERVENTIONAL Chicago, Illinois
RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
NAINTERVENTIONAL Chicago, Illinois +1 more
RECRUITING
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
N/AOBSERVATIONAL Chicago, Illinois +4 more
RECRUITING
Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
PHASE3INTERVENTIONAL Evanston, Illinois
RECRUITING
Filter Trials
Trial Phase
Study Type